Michael Firer

Michael Firer

Apr 18, 2022

Group 6 Copy 15
0
    Please wait...

    About This Project

    Anti-Phospholipid Syndrome (APS) is an autoimmune disease in which certain antibodies cause blood clotting. These antibodies are an important cause of spontaneous miscarriage in women aged 20-50 years. There is no effective treatment for APS. Our project will test whether small peptides we have discovered, can block the activity of these antibodies. Positive results from these experiments will support further development of the peptides as a new therapy for APS.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    Can we make anesthesia for dogs safer with the help of nutrition?

    Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...